Sometimes we all struggle to try and understand what we are looking at. Here’s a sentence from a paper we have just been reading: “After transduction of myristolated-AKT (a serine/threonine protein kinase) and ERG (an ets family transcription factor), lesions resembling [PIN] … developed.” … READ MORE …
Filed under: Uncategorized | Tagged: origin, stem cell, theory | Leave a comment »
An article in this week’s New England Journal of Medicine has argued that an earlier report, postulating the monoclonal origin of lethal metastatic prostate cancer, increases the justification for focal therapy for early stage prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: focal therapy, origin | 3 Comments »
On Tuesday this week we reported on a study suggesting that some prostate cancers might be caused by the XMRV virus. Now comes a study suggesting that specific types of stems cells may be implicated in the development of some prostate cancers. … READ MORE …
Filed under: Prevention | Tagged: cause, origin, stem cells | Leave a comment »
Today’s news reports focus on four items:
Filed under: Drugs in development, Management, Treatment | Tagged: CRPC, development, gefitinib, origin, positive surgical margins, prostate size, surgery, urinary function | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 